Goldman Sachs’s Odonate Therapeutics, Inc. Common Stock ODT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-58,210
| Closed | -$79K | – | 6100 |
|
|
2021
Q4 | $79K | Buy |
58,210
+12,050
| +26% | +$16.4K | ﹤0.01% | 5274 |
|
|
2021
Q3 | $134K | Sell |
46,160
-47,658
| -51% | -$138K | ﹤0.01% | 4993 |
|
|
2021
Q2 | $327K | Buy |
93,818
+20,581
| +28% | +$71.7K | ﹤0.01% | 4660 |
|
|
2021
Q1 | $251K | Sell |
73,237
-10,119
| -12% | -$34.7K | ﹤0.01% | 4728 |
|
|
2020
Q4 | $1.6M | Sell |
83,356
-3,259
| -4% | -$62.6K | ﹤0.01% | 3196 |
|
|
2020
Q3 | $1.16M | Buy |
86,615
+59,126
| +215% | +$794K | ﹤0.01% | 3223 |
|
|
2020
Q2 | $1.16M | Buy |
27,489
+16,537
| +151% | +$700K | ﹤0.01% | 3141 |
|
|
2020
Q1 | $302K | Sell |
10,952
-11,928
| -52% | -$329K | ﹤0.01% | 3747 |
|
|
2019
Q4 | $743K | Sell |
22,880
-25,392
| -53% | -$825K | ﹤0.01% | 3474 |
|
|
2019
Q3 | $1.26M | Buy |
48,272
+41,183
| +581% | +$1.07M | ﹤0.01% | 3121 |
|
|
2019
Q2 | $260K | Sell |
7,089
-3,682
| -34% | -$135K | ﹤0.01% | 3769 |
|
|
2019
Q1 | $238K | Buy |
+10,771
| New | +$238K | ﹤0.01% | 3827 |
|
|
2018
Q4 | – | Sell |
-16,701
| Closed | -$324K | – | 4321 |
|
|
2018
Q3 | $324K | Buy |
+16,701
| New | +$324K | ﹤0.01% | 3642 |
|
|
2018
Q2 | – | Sell |
-31,871
| Closed | -$675K | – | 4376 |
|
|
2018
Q1 | $675K | Buy |
31,871
+5,491
| +21% | +$116K | ﹤0.01% | 3356 |
|
|
2017
Q4 | $660K | Buy |
+26,380
| New | +$660K | ﹤0.01% | 3325 |
|